Events

The Indo US Bridging RARE Summit 2025 brings together global experts, researchers, industry leaders, and patient advocates to strengthen the framework for inclusive and accessible clinical research in rare diseases.

This three-day hybrid summit features keynote sessions, networking opportunities, a Pitch4RARE startup contest, and a Gala Dinner & Awards Ceremony, all designed to accelerate cross-border collaboration in orphan drug development—particularly between the U.S. and India.

Researchers, clinicians, startups, and patient organizations are invited to participate in sessions covering data governance, clinical trials, DEIA in research, and emerging innovations in rare-disease care.

Organized in collaboration with IndoUSRare and George Mason University, the #BridgingRare Summit 2025 will feature an exciting lineup of prominent speakers from India and the US, workshops, and a Gala dinner and Award Ceremony.

Learn more and register here today! Indo US Bridging RARE Summit 2025

Key Objectives & Highlights

• The Summit aims to accelerate engagement of the global rare disease community in orphan drug R&D, fostering collaboration especially between India and the U.S.

• Attendees will benefit from educational sessions, networking opportunities, and deep dives into topics with a focus on emerging markets – particularly India.

• The hybrid format allows both on-site and virtual access to content and networking tools.

• A Gala Dinner & Awards Ceremony is included as a culminating event.

• The Pitch4RARE contest invites startups and innovators developing rare-disease diagnostics, therapies, or digital health tools to present ideas to key stakeholders.

• Researchers and clinicians are encouraged to submit abstracts along thematic tracks such as:

  • Cross-border patient engagement

  • Comparative care pathways (screening, diagnosis, treatment)

  • Data privacy & governance

  • Clinical trials for orphan drugs

  • Regulatory pathways

  • Diversity, Equity, Inclusion & Accessibility (DEIA) in orphan drug research